Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON21792
NL-OMON21792
Not Yet Recruiting
N/A

Study evaluating ease of use, preference and satisfaction of two different Fluticason/salmeterol inhalers in asthma or COPD COPD patients.

Medisch Spectrum Twente, Enschede0 sites110 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsasthmaastmaCOPDchronische bronchitislongemfyseem

Overview

Phase
N/A
Intervention
Not specified
Conditions
asthmaastmaCOPDchronische bronchitislongemfyseem
Sponsor
Medisch Spectrum Twente, Enschede
Enrollment
110
Status
Not Yet Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Medisch Spectrum Twente, Enschede

Eligibility Criteria

Inclusion Criteria

  • •1\. Adult male or female patients aged \> 40 with stable COPD or asthma;
  • •2\. Patients have to be naïve to the study inhalers, Accuhaler/Diskus and Elpenhaler for at least 1 year;

Exclusion Criteria

  • •1\. Patients currently participating in another randomised clinical trial;
  • •2\. Patients with body malformations or diseases affecting coordination and/or motor system;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Study evaluating ease of use, preference and satisfaction of two different Fluticason/salmeterol inhalers in asthma or COPD patientsAsthmaCOPD10006436
NL-OMON35747Medisch Spectrum Twente110
Active, Not Recruiting
Phase 1
To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapychildren aged 6 years or more receiving growth hormone therapy for the following approved indications (according to Norditropine SPC)-GHD-Turner Syndrome-small for gestational age-chronic renal insufficiency
EUCTR2009-017387-16-FRovo Nordisk Pharmaceutique S.A.S
Completed
N/A
Study evaluating preference, satisfaction and ease of use of inhalers in COPD diagnosed patientschronic obstructive lung diseasesmokers lung10038716
NL-OMON35964Almirall60
Completed
N/A
Smartphone Intervention for Subthreshold DepressionSubthreshold Depression
NCT03110016Kibi International University22
Completed
N/A
Outcomes and User Acceptance of the IntelliVue Alarm Advisor Software (Europe)Clinical Alarms
NCT03182452Philips Healthcare1,487